Valeo Pharma appoints new chairman
This article was originally published in Scrip
Executive Summary
Valeo Pharma (Canada) has appointed Richard MacKay chairman. Mr MacKay previously served as both vice-chairman of the board of directors of Stiefel Laboratories, which was acquired by GlaxoSmithKline for $3.6 billion in July 2009 (scripnews.com, July 20th, 2009), and as president of Stiefel Canada; he retired from both roles recently.